Richard Aguilar - 28 Jun 2023 Form 4 Insider Report for Cano Health, Inc.

Role: Chief Clinical Officer
Signature: /s/ David J. Armstrong, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 28 Jun 2023
Net transactions value: -$709,060
Form type: 4
Filing time: 30 Jun 2023, 16:43:09 UTC
Previous filing: 28 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CANO	Class A Common Stock	Sale	$183,300	-150,000	-8.5%	$1.22	1,613,984	28 Jun 2023	Direct	F1
transaction	CANO	Class A Common Stock	Sale	$525,760	-400,000	-25%	$1.31	1,213,984	29 Jun 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2	The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.30 to $1.345. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.21 to $1.24. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.30 to $1.345. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.